Cytek Biosciences CTKB Stock
Cytek Biosciences Price Chart
Cytek Biosciences CTKB Financial and Trading Overview
| Cytek Biosciences stock price | 4.07 USD |
| Previous Close | 3.77 USD |
| Open | 3.82 USD |
| Bid | 2.8 USD x 200 |
| Ask | 4.88 USD x 200 |
| Day's Range | 3.77 - 3.95 USD |
| 52 Week Range | 3.09 - 6.18 USD |
| Volume | 1.87M USD |
| Avg. Volume | 1.2M USD |
| Market Cap | 498.49M USD |
| Beta (5Y Monthly) | 1.186 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.58 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.69 USD |
CTKB Valuation Measures
| Enterprise Value | 263.75M USD |
| Trailing P/E | N/A |
| Forward P/E | 20.315788 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.4415336 |
| Price/Book (mrq) | 1.5214821 |
| Enterprise Value/Revenue | 1.292 |
| Enterprise Value/EBITDA | -7.265 |
Trading Information
Cytek Biosciences Stock Price History
| Beta (5Y Monthly) | 1.186 |
| 52-Week Change | 19.50% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 6.18 USD |
| 52 Week Low | 3.09 USD |
| 50-Day Moving Average | 4.22 USD |
| 200-Day Moving Average | 4.48 USD |
CTKB Share Statistics
| Avg. Volume (3 month) | 1.2M USD |
| Avg. Daily Volume (10-Days) | 3.44M USD |
| Shares Outstanding | 129.14M |
| Float | 96.54M |
| Short Ratio | 7.05 |
| % Held by Insiders | 8.41% |
| % Held by Institutions | 67.58% |
| Shares Short | 7.3M |
| Short % of Float | 7.16% |
| Short % of Shares Outstanding | 5.65% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -36.24% |
| Operating Margin (ttm) | -41.83% |
| Gross Margin | 51.70% |
| EBITDA Margin | -17.78% |
Management Effectiveness
| Return on Assets (ttm) | -5.88% |
| Return on Equity (ttm) | -20.92% |
Income Statement
| Revenue (ttm) | 204.17M USD |
| Revenue Per Share (ttm) | 1.6 USD |
| Quarterly Revenue Growth (yoy) | 6.50% |
| Gross Profit (ttm) | 105.56M USD |
| EBITDA | -36303000 USD |
| Net Income Avi to Common (ttm) | -74003000 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 262.22M USD |
| Total Cash Per Share (mrq) | 2.03 USD |
| Total Debt (mrq) | 27.48M USD |
| Total Debt/Equity (mrq) | 8.39 USD |
| Current Ratio (mrq) | 4.687 |
| Book Value Per Share (mrq) | 2.537 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7297000 USD |
| Levered Free Cash Flow (ttm) | 6.41M USD |
Profile of Cytek Biosciences
| Country | United States |
| State | CA |
| City | Fremont |
| Address | 47215 Lakeview Blvd |
| ZIP | 94538-6407 |
| Phone | 877 922 9835 |
| Website | https://cytekbio.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 678 |
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Q&A For Cytek Biosciences Stock
What is a current CTKB stock price?
Cytek Biosciences CTKB stock price today per share is 4.07 USD.
How to purchase Cytek Biosciences stock?
You can buy CTKB shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cytek Biosciences?
The stock symbol or ticker of Cytek Biosciences is CTKB.
Which industry does the Cytek Biosciences company belong to?
The Cytek Biosciences industry is Medical Devices.
How many shares does Cytek Biosciences have in circulation?
The max supply of Cytek Biosciences shares is 129.14M.
What is Cytek Biosciences Price to Earnings Ratio (PE Ratio)?
Cytek Biosciences PE Ratio is now.
What was Cytek Biosciences earnings per share over the trailing 12 months (TTM)?
Cytek Biosciences EPS is -0.58 USD over the trailing 12 months.
Which sector does the Cytek Biosciences company belong to?
The Cytek Biosciences sector is Healthcare.
Cytek Biosciences CTKB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
4123.39 USD — |
-2.34
|
— — | 4089.8 USD — | 4163.55 USD — | — - | — — |
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3090.39 USD — |
-0.26
|
— — | 3063.94 USD — | 3108.39 USD — | — - | — — |
- {{ link.label }} {{link}}


